Although not disease-specific, anti-Ro52/TRIM21 antibody is a highly frequent and established prognostic biomarker, being an independent risk factor for disease severity and relapse in connective tissue diseases, and of lung involvement in patients with IIMs [36,37,38,39]. Here, TRIM21 is linked to connective tissue disorder.